Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by Str8Shuteron Oct 19, 2020 2:29pm
170 Views
Post# 31742177

RE:RE:Selling pressure

RE:RE:Selling pressureFunny how an 8 cent intraday swing in the SP looks so unusual now.  The SP trading at $0.84 plus or minus $0.04 today is a deviation of plus or minus 4.8% from the median.

That is actually remarkably less intraday volatility than when the pre-consolidation shares were trading up or down by a half a penny.  For example, for weeks prior to the RS, the SP would often trade intraday between $0.05 and $0.06.  The SP trading at $0.055 plus or minus $0.005 was a variance of plus or minus 9.1% from the median.  It was a fairly common intraday trading range, and people seemed to get used to it.

I think that there was considerably more short trading activity before the RS, but as a longer term investor it doesn't hurt to have a healthy "stink bid" in place just in case someone dumps a pile of shares for some reason (e.g. to seriously "shake the tree") before the Q3 report.  GLTA!


WHATTHE1 wrote:
Shorters trying to shake the tree! No a reall lot of volume selling down. Good things await.


<< Previous
Bullboard Posts
Next >>